News from takeda pharmaceuticals north america, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Aug 02, 2016, 02:00 ET Takeda and TiGenix Announce Publication in The Lancet of 24-Week Results of the Phase 3 ADMIRE-CD Trial Investigating Cx601 in the Treatment of Complex Perianal Fistulas in Patients with Crohn's Disease

Takeda Pharmaceutical Company Limited (TSE: 4502) ("Takeda") and TiGenix NV (Euronext Brussels: TIG) ("TiGenix") today announced that the 24-week...


Jul 15, 2016, 13:00 ET Takeda Aims To Raise $500,000 for Team Challenge for Crohn's & Colitis

Some will be walking and others will be running but all will have smiles on their faces as more than 100 employees of Takeda Pharmaceuticals cross...


Jul 05, 2016, 02:00 ET Takeda and TiGenix Enter into Licensing Agreement for Ex-U.S. Rights to Cx601 for the Treatment of Complex Perianal Fistulas in Patients with Crohn's Disease

 Takeda Pharmaceutical Company Limited (TSE: 4502) ("Takeda") and TiGenix NV (Euronext Brussels: TIG) ("TiGenix") today announced that the...


Jun 11, 2016, 13:31 ET EXAMINE Trial Post-Hoc Analyses of Mortality Data Regarding Cardiovascular Safety of Alogliptin Presented at American Diabetes Association's 76th Scientific Sessions and Published in Diabetes Care

Takeda Pharmaceutical Company Limited [TSE: 4502], ("Takeda") announced the publication of a post-hoc analysis from the global EXAMINE (EXamination...


Jun 08, 2016, 08:29 ET Takeda Licenses Global Rights to Theravance Biopharma's TD-8954, a Novel 5-HT4 Agonist and Motility Agent for Gastrointestinal Motility Disorders

Takeda Pharmaceutical Company Limited (TSE: 4502) ("Takeda") and Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma") today announced...


Jun 06, 2016, 09:38 ET Takeda to Present New Data at the American Diabetes Association's 76th Scientific Sessions

 Takeda Pharmaceuticals Company Limited [TSE: 4502], ("Takeda") will present eight abstracts at the American Diabetes Association's 76th...


Jun 06, 2016, 07:00 ET Roivant Sciences and Takeda Launch Myovant Sciences to Develop Innovative Therapeutics for Women's Health and Prostate Cancer

 Takeda Pharmaceutical Company Limited (TSE: 4502) and Roivant Sciences Ltd. today announced the formation of Myovant Sciences Ltd....


May 23, 2016, 12:33 ET Takeda Presents Analyses From Vedolizumab Data in Ulcerative Colitis at 2016 Digestive Disease Week (DDW) Annual Meeting

Takeda Pharmaceutical Company Limited [TSE: 4502], ("Takeda") today announced the oral presentations of two data analyses: one evaluating the...


May 02, 2016, 07:00 ET Prosetta Biosciences, Inc. And Takeda Pharmaceutical Company Limited, Enter Into Agreement To Discover And Develop Novel Compounds For Neurodegenerative Diseases

Prosetta Biosciences, Inc. (the "Company," or "Prosetta"), today announced that it has entered into a Feasibility and First Right of Negotiation...


Apr 28, 2016, 13:00 ET Takeda Expands Its Help At Hand Patient Assistance Program in U.S.; Reaches Even More Eligible Patients in the U.S.

Takeda today announced its U.S. Business Unit will expand its patient assistance program to make its prescription drugs available to more eligible...


Mar 28, 2016, 20:02 ET Takeda and Lundbeck Receive Complete Response Letter for Brintellix® (vortioxetine) sNDA

 Takeda Pharmaceutical Company Limited (Takeda) and H. Lundbeck A/S (Lundbeck) today announced that the U.S. Food and Drug...


Mar 15, 2016, 07:00 ET Orexigen and Takeda Jointly Announce Orexigen's Acquisition of All Rights to CONTRAVE® in the United States

 Orexigen Therapeutics, Inc. (Nasdaq: OREX) and Takeda Pharmaceuticals U.S.A., Inc., a wholly-owned subsidiary of Takeda Pharmaceutical...


Feb 03, 2016, 20:36 ET FDA Psychopharmacologic Drug Advisory Committee Supports the Effectiveness of Brintellix® (vortioxetine) in Treating Certain Aspects of Cognitive Dysfunction in Major Depressive Disorder (MDD)

 Takeda Pharmaceutical Company Limited (Takeda) and H. Lundbeck A/S (Lundbeck) today announced that the U.S. Food and Drug Administration's...


Nov 13, 2015, 10:18 ET Takeda Receives Back-to-Back Recognition, Named a 2015 Top Chicago Workplace

 Takeda announced today that the Chicago Tribune named Takeda's Deerfield campus among Chicago's Top 100 Workplaces in 2015. This is the fourth...


Aug 10, 2015, 18:36 ET FDA Accepts a Supplemental New Drug Application for Review of Brintellix® (vortioxetine) Clinical Trial Data That Assessed Cognitive Function in Patients with Major Depressive Disorder

Takeda Pharmaceutical Company Limited (Takeda) and H. Lundbeck A/S (Lundbeck) announced today the U.S. Food and Drug Administration (FDA) has...


Jun 05, 2015, 17:15 ET Takeda Presents Additional Data from Alogliptin's EXAMINE Cardiovascular Safety Outcomes Trial at the American Diabetes Association's 75th Scientific Sessions

Takeda Pharmaceutical Company Limited, ("Takeda") today announced additional post-hoc analyses from the global EXAMINE (EXamination of...


May 15, 2015, 02:26 ET Takeda Reports Top Line Results in Line With Guidance, With Underlying Growth of +2.8% EPS Affected by One-time Charges in FY2014 Back to Profitable Growth from FY2015 Onward

Operational guidance met  - Underlying revenue +2.8% year-over-year, in line with guidance (reported revenue growing +5.1% to 1,777.8...


Apr 27, 2015, 05:05 ET TWi Announces Settlement with Takeda on Dexilant(R) Litigation

TWi Pharmaceuticals, Inc. ("TWi") today announced that it has entered into a Settlement Agreement with Takeda Pharmaceutical Company Limited,...


Apr 14, 2015, 19:00 ET FDA Advisory Committee Reviews Takeda's Alogliptin EXAMINE Cardiovascular Safety Outcomes Trial

Takeda Pharmaceuticals U.S.A. Inc. and Takeda Pharmaceutical Company Limited, ("Takeda") today announced that members of the Endocrinologic and...


Apr 13, 2015, 08:40 ET Takeda Announces Appointment of New President of U.S. Business Unit

 Takeda Pharmaceutical Company Limited ("Takeda"), and Takeda's wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. ("TPUSA")...


Mar 09, 2015, 20:20 ET Takeda Announces Publication in The Lancet of a Post Hoc Analysis of Data from the EXAMINE Cardiovascular Safety Outcomes Trial

Takeda Pharmaceutical Company Limited (Takeda) announced that a post hoc analysis of data from the global EXAMINE (EXamination of CArdiovascular...


Mar 09, 2015, 13:15 ET Takeda Hosts Investor Briefing on its Global Leadership in Gastroenterology

 Takeda Pharmaceutical Company Limited ("Takeda") today held a briefing for investors and analysts in New York, discussing the company's...


Aug 28, 2014, 12:09 ET Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS

Takeda Pharmaceutical Company Limited ("Takeda") today announced the completion of the post-marketing commitment and submissions of data from...


Apr 08, 2014, 09:16 ET Lilly Responds to Verdict in Case of Terrence Allen, et al. v. Takeda

 Eli Lilly and Company (NYSE: LLY) issued the following statement today in response to the verdict in the case of Terrence Allen, et al. v....


Mar 27, 2014, 08:00 ET Takeda Presents Additional Data from the EXAMINE Cardiovascular Safety Outcomes Trial at the American College of Cardiology's 63rd Annual Scientific Session

Takeda Pharmaceutical Company Limited (Takeda) will present sub-analyses from the global EXAMINE (EXamination of CArdiovascular OutcoMes:...